ClearPoint Neuro (CLPT) Free Cash Flow (2011 - 2026)

ClearPoint Neuro (CLPT) has 15 years of Free Cash Flow data on file, last reported at -$8.6 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 35.52% year-over-year to -$8.6 million; the trailing twelve-month figure through Mar 2026 stood at -$26.7 million (down 127.25% YoY), and the FY2025 full-year result was -$24.4 million, down 164.74% from the prior year.
• Free Cash Flow improved to -$8.6 million in Q1 2026, from -$12.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$1.2 million in Q4 2023 to a low of -$12.1 million in Q4 2025.
• A 5-year average of -$4.3 million and a median of -$3.8 million in 2024 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow soared 61.66% in 2023 and plunged 706.71% in 2025, its largest moves.
• Tracing CLPT's Free Cash Flow over 5 years: stood at -$3.1 million in 2022, then soared by 61.66% to -$1.2 million in 2023, then retreated by 26.55% to -$1.5 million in 2024, then sank by 706.71% to -$12.1 million in 2025, then climbed by 29.11% to -$8.6 million in 2026.
• Business Quant data shows CLPT's Free Cash Flow at -$8.6 million in Q1 2026, -$12.1 million in Q4 2025, and -$3.3 million in Q3 2025.